Adams Asset Advisors’s Celgene Corp CELG Stock Holding History

Adams Asset Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,510	Closed	-$493K	–	100
2018 Q3	$493K	Buy	+5,510	New	+$487K	0.05%	91
2018 Q2	–	Sell	-8,610	Closed	-$768K	–	108
2018 Q1	$768K	Buy	8,610 +110	+1%	+$10.6K	0.1%	75
2017 Q4	$887K	Hold	8,500	–	–	0.11%	76
2017 Q3	$1.24M	Hold	8,500	–	–	0.17%	59
2017 Q2	$1.1M	Hold	8,500	–	–	0.16%	64
2017 Q1	$1.06M	Hold	8,500	–	–	0.15%	67
2016 Q4	$984K	Hold	8,500	–	–	0.13%	68
2016 Q3	$888K	Hold	8,500	–	–	0.12%	68
2016 Q2	$838K	Hold	8,500	–	–	0.14%	62
2016 Q1	$850K	Buy	8,500 +1,000	+13%	+$103K	0.16%	62
2015 Q4	$898K	Hold	7,500	–	–	0.17%	61
2015 Q3	$811K	Buy	7,500 +4,500	+150%	+$558K	0.15%	65
2015 Q2	$347K	Buy	+3,000	New	+$343K	0.06%	87

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adams Asset Advisors's CELG Position: Q4 2018 in Review

Adams Asset Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 5,510 shares — an estimated $493K sold.

Adams Asset Advisors first reported a position in CELG in Q2 2015 and held it in 13 quarters. The position peaked at $1.24M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Adams Asset Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Adams Asset Advisors sold 5,510 Celgene Corp shares in Q4 2018, an estimated $493K.
Adams Asset Advisors first reported a position in Celgene Corp in Q2 2015 and held it in 13 quarters.
Adams Asset Advisors's Celgene Corp position peaked at $1.24M in Q3 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Adams Asset Advisors's 13F filing for Q4 2018, filed 10 Jan 2019.